A
Anthony T. Newall
Researcher at University of New South Wales
Publications - 98
Citations - 4892
Anthony T. Newall is an academic researcher from University of New South Wales. The author has contributed to research in topics: Cost effectiveness & Vaccination. The author has an hindex of 30, co-authored 94 publications receiving 3733 citations. Previous affiliations of Anthony T. Newall include University of Sydney & Children's Medical Research Institute.
Papers
More filters
Journal ArticleDOI
The potential cost-effectiveness of infant pneumococcal vaccines in Australia.
TL;DR: To evaluate the cost-effectiveness of PCV programs, a static, deterministic state-transition model was developed and assumptions regarding herd protection, serotype protection, otitis media efficacy, and vaccination cost changed the relative cost-Effectiveness of alternative PCVs.
Journal ArticleDOI
Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies.
TL;DR: Population prepandemic vaccine and antiviral treatment strategies may be cost-effective and effective in relation to infectious disease prevention and treatment.
Journal ArticleDOI
Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: A review of the current status of the clinical development pipeline
Erin Sparrow,Siranda Torvaldsen,Anthony T. Newall,James G. Wood,Mohamud Sheikh,Marie Paule Kieny,Bernadette Abela-Ridder +6 more
TL;DR: The current landscape of the clinical trial development of anti-rabies monoclonal antibodies and the historical clinical trial pathways followed for blood-derived rabies immunoglobulin are reviewed before discussing challenges in the clinical evaluation, regulatory approval, uptake and monitoring of these products.
Journal ArticleDOI
A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly
TL;DR: Emerging trial evidence on PCV13 in adults from the Netherlands offers the ability to parameterize future economic evaluations with empirical efficacy data, however, it is important that these estimates are used thoughtfully when they are transferred to other settings.
Journal ArticleDOI
Risk factors for herpes zoster in a large cohort of unvaccinated older adults: a prospective cohort study
Bette Liu,Anita E. Heywood,Joanne Reekie,Emily Banks,John M. Kaldor,Peter McIntyre,Anthony T. Newall,Chandini Raina MacIntyre +7 more
TL;DR: The novel finding of an increased risk of zoster diagnoses and hospitalizations in those with physical limitations should prompt evaluation of the use of the zoster vaccine in this population of adults.